NS · Healthcare

Parnax Lab Ltd (506128)

Pharmaceuticals & Biotechnology

Parnax Lab Ltd (506128) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.53B, P/E ratio is 173.18, net margin is 16.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 506128

Market cap

$1.53B

P/E ratio

173.18

Net margin

16.9%

Parnax Lab Ltd (506128) — FAQ

What is Parnax Lab Ltd's market cap?

Parnax Lab Ltd (506128) has a reported market cap of $1.53B (data as of 2026-07-10).

What is 506128's P/E ratio?

The price-to-earnings (P/E) ratio for Parnax Lab Ltd (506128) is 173.18 (data as of 2026-07-10).

Does Parnax Lab Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Parnax Lab Ltd (506128). Check the MyAverix Finance app for the latest dividend data.

What sector is Parnax Lab Ltd in?

Parnax Lab Ltd (506128) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 506128 listed on?

506128 is listed on NS.

What is Parnax Lab Ltd's net margin?

Parnax Lab Ltd (506128) reports a net margin of 16.9% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)